Bristol-Myers Hepatitis Drug Effective - FDA Staff (Reuters


Reuters - Bristol-Myers Squibb Co.'s.
experimental drug for chronic hepatitis B infection is
effective in treating the liver disease, but also raises
questions about cancer risks, U.S. regulatory staff said in
documents released on Thursday.

Read more...